Characteristics and management of patients with renal anaemia treated with daprodustat: an observational study in Japan
Approximately a third (DD) to almost half (ND) of patients with renal anaemia were not receiving treatment for anaemia. An increase in haemoglobin levels was observed after initiation of daprodustat, including in patients previously treated with erythropoiesis-stimulating agents, however causality cannot be confirmed due to lack of a control group.
Authors
- Hirofumi Ozeki (ORCID: https://orcid.org/0000-0003-4737-8708)
- Masao Yarita (ORCID: https://orcid.org/0000-0001-5770-4496)
- Masashi Takano (ORCID: https://orcid.org/0000-0002-4625-3762)
- Ai Hayashi
- Kazuko Suzuki (ORCID: https://orcid.org/0000-0002-0108-0896)
- Sakiyo Tsukamoto
- Yasuo Nakajima
Institutions
- Health Economics and Outcomes Research (United Kingdom) (GB)
- Diagnostics for the Real World (United Kingdom) (GB)
- National Patient Safety Foundation (US)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2025-08-03
- DOI
- https://doi.org/10.1080/03007995.2025.2556321
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00